SENISCA
Splicing Factors for Cell RejuvenationSENISCA
senisca.com| BioTech | Exeter, UK
ABOUT
SENISCA developed a patent protected approach to treat ageing and ageing related diseases. As we age, cells become aged, or ‘senescent’ and they behave differently, which leads to tissue and organ damage. SENISCA discovered that splicing regulation declines during ageing and that cells could not only be brought out of senescence but that, by doing so, the cells were also rejuvenated.
FOUNDERS
Dr. Lorna Harries, Dr. Ben Lee, Kristy Semple
CO-INVESTORS
Longevitytech.fund, R42 Group, University of Exeter
INDUSTRY
BioTech, Longevity
FOLLOW SENISCA
Copyright 2023
APEX Ventures GmbH